Kenji Tsushima Selected Research

Kenji Tsushima Research Topics

Disease

19	Lung Injury 01/2022 - 03/2004
11	Idiopathic Pulmonary Fibrosis 01/2020 - 12/2014
9	Neoplasms (Cancer) 01/2022 - 01/2007
8	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2019 - 01/2010
7	Respiratory Insufficiency (Respiratory Failure) 07/2022 - 01/2010
7	COVID-19 07/2022 - 01/2021
6	Pneumonia (Pneumonitis) 07/2022 - 05/2014
6	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2007
6	Disease Progression 04/2018 - 01/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 01/2004
5	Acute Lung Injury 12/2012 - 01/2002
3	Bacterial Pneumonia 07/2022 - 05/2014
3	Hemorrhage 01/2020 - 03/2004
3	Pulmonary Hypertension 04/2019 - 11/2010
3	Dyspnea (Shortness of Breath) 04/2019 - 01/2013
3	Pathologic Constriction (Stenosis) 01/2016 - 01/2007
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2014 - 01/2002
3	Fistula 10/2009 - 07/2004
2	Fever (Fevers) 12/2021 - 01/2015
2	Obesity 12/2021 - 01/2006
2	Inflammation (Inflammations) 04/2018 - 10/2009
2	Disseminated Intravascular Coagulation 01/2015 - 12/2014
2	Seminoma 08/2013 - 01/2008
2	Hyperplasia 11/2011 - 01/2006
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2010 - 06/2009
2	Hypoxia (Hypoxemia) 01/2010 - 01/2010
2	Pulmonary Edema 07/2008 - 07/2004
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 12/2007 - 10/2006
2	Thymoma (Thymic Carcinoma) 07/2007 - 06/2002
2	Sepsis (Septicemia) 04/2007 - 01/2007
2	Tracheal Stenosis 01/2007 - 09/2006
1	Infections 07/2022
1	Body Weight (Weight, Body) 01/2022
1	Collagen Diseases (Collagen Disease) 12/2021

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2022 - 03/2008
7	Oxygen (Dioxygen)IBA 07/2022 - 03/2010
6	AcidsIBA 11/2010 - 03/2004
5	nintedanibIBA 01/2020 - 01/2018
5	Cisplatin (Platino)FDA LinkGeneric 08/2013 - 06/2002
5	CytokinesIBA 01/2012 - 03/2004
5	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2010 - 01/2002
4	Immunoglobulin G (IgG)IBA 05/2011 - 01/2006
3	Gemcitabine FDA Link 01/2022 - 01/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2013
3	ThrombomodulinIBA 01/2020 - 12/2014
3	pirfenidoneIBA 01/2019 - 01/2017
3	Secretory Proteinase Inhibitory ProteinsIBA 06/2014 - 12/2004
3	AlbuminsIBA 12/2012 - 03/2004
3	Hydrochloric Acid (Hydrogen Chloride)FDA Link 02/2010 - 03/2004
2	ProcalcitoninIBA 07/2022 - 07/2022
2	C-Reactive ProteinIBA 07/2022 - 07/2022
2	SteroidsIBA 07/2022 - 07/2022
2	favipiravirIBA 07/2022 - 12/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2010
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2018
2	Everolimus FDA Link 01/2018 - 01/2013
2	AntigensIBA 07/2013 - 12/2007
2	InterleukinsIBA 12/2012 - 03/2004
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2012 - 07/2004
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 11/2011
2	Interleukin-13IBA 11/2011 - 01/2006
2	sivelestatIBA 09/2010 - 12/2004
2	LipopolysaccharidesIBA 04/2010 - 03/2010
2	Chemotactic FactorsIBA 02/2010 - 03/2004
2	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2010 - 06/2009
2	Oleic Acid (Oleate)IBA 10/2009 - 07/2008
2	Docetaxel (Taxotere)FDA Link 05/2009 - 05/2009
2	Carboplatin (JM8)FDA LinkGeneric 07/2007 - 12/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007 - 06/2002
2	Vincristine (Oncovin)FDA LinkGeneric 07/2007 - 06/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2007 - 06/2002
2	EndotoxinsIBA 04/2007 - 07/2004
1	camostatIBA 07/2022
1	ciclesonide FDA Link 07/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	antithrombin III-protease complexIBA 12/2021
1	plasmin-plasmin inhibitor complexIBA 12/2021
1	Fibrinogen (Factor I)FDA Link 12/2021
1	fibrin fragment D (D-dimer)IBA 12/2021

Therapy/Procedure

16	Therapeutics 07/2022 - 01/2004
11	Drug Therapy (Chemotherapy) 09/2019 - 06/2002
6	Artificial Respiration (Mechanical Ventilation) 07/2022 - 01/2007
5	Hemoperfusion 01/2010 - 01/2002
4	Cannula 07/2022 - 01/2006
3	Extracorporeal Membrane Oxygenation 07/2022 - 05/2018
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 07/2022 - 02/2012
3	Noninvasive Ventilation 01/2021 - 01/2010
3	Radiotherapy 09/2017 - 05/2009
3	Radiofrequency Ablation 01/2015 - 04/2010
3	Vascular Access Devices (Arterial Line) 10/2009 - 07/2004
2	Respiratory Therapy (Therapy, Respiratory) 07/2022 - 07/2022
2	Length of Stay 01/2022 - 01/2008
2	Lung Transplantation 05/2018 - 09/2016
2	Catheters 04/2010 - 01/2007
2	Argon Plasma Coagulation 01/2007 - 09/2006
1	Patient Discharge 07/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Blood Component Removal (Apheresis) 12/2021